Published in Ann N Y Acad Sci on July 26, 2007
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med (2010) 4.61
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov (2012) 4.40
The role of inflammation in epilepsy. Nat Rev Neurol (2010) 3.89
Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci (2008) 1.84
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One (2012) 1.59
Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A (2008) 1.55
Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia (2009) 1.26
Brain inflammation as a biomarker in epilepsy. Biomark Med (2011) 1.23
A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity (2009) 1.14
Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [¹⁸F]-IL1RA and PET imaging in rats. Br J Pharmacol (2011) 1.07
Neuroprotective activities of CEP-1347 in models of neuroAIDS. J Immunol (2009) 0.98
Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur J Nutr (2011) 0.97
Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis (2009) 0.94
Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture. J Psychosom Res (2014) 0.91
Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia (2012) 0.85
Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury. J Transplant (2013) 0.83
Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia. Int J Alzheimers Dis (2010) 0.81
Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay. J Interferon Cytokine Res (2013) 0.81
Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation. Expert Rev Neurother (2013) 0.80
Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model. Front Pharmacol (2013) 0.79
The inflammatory molecules IL-1β and HMGB1 can rapidly enhance focal seizure generation in a brain slice model of temporal lobe epilepsy. Front Cell Neurosci (2014) 0.79
Blocking IL-1beta to slow down progression of ALS? Proc Natl Acad Sci U S A (2010) 0.79
Nervous system involvement in clinical peripheral inflammation: A description of three pediatric cases. J Pediatr Neurosci (2016) 0.78
Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model. AAPS J (2015) 0.77
Acute lipopolysaccharide exposure facilitates epileptiform activity via enhanced excitatory synaptic transmission and neuronal excitability in vitro. Neuropsychiatr Dis Treat (2014) 0.77
Generation of Febrile Seizures and Subsequent Epileptogenesis. Neurosci Bull (2016) 0.76
Age-Dependent Neuroimmune Modulation of IGF-1R in the Traumatic Mice. Immun Ageing (2012) 0.75
Interleukin-1β activates an Src family kinase to stimulate the plasma membrane Ca2+ pump in hippocampal neurons. J Neurophysiol (2016) 0.75
The Effect of Quercetin on Pro- and Anti-Inflammatory Cytokines in a Prenatally Stressed Rat Model of Febrile Seizures. J Exp Neurosci (2017) 0.75
The Gut-brain Axis: A New Pathogenic View of Neurologic Symptoms - Description of a Pediatric Case. J Pediatr Neurosci (2017) 0.75
The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia (2010) 6.23
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med (2010) 4.61
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development (2004) 3.75
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science (2011) 3.48
Transgenic mice with a reduced core body temperature have an increased life span. Science (2006) 3.37
Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol (2005) 2.90
Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis (2007) 2.81
Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science (2004) 2.00
A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci (2006) 1.93
Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci (2010) 1.87
IL-1 family nomenclature. Nat Immunol (2010) 1.79
Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci (2004) 1.66
A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain (2008) 1.64
CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci U S A (2009) 1.57
Glia and epilepsy: excitability and inflammation. Trends Neurosci (2013) 1.49
Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. J Neurosci (2002) 1.44
Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol (2005) 1.41
Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol (2012) 1.41
Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A (2007) 1.40
Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma (2002) 1.40
Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis (2005) 1.39
Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis (2003) 1.39
Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis (2008) 1.39
Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics (2011) 1.36
Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci (2003) 1.36
Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain (2008) 1.36
Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci (2003) 1.32
Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.26
Interleukin 18 in the CNS. J Neuroinflammation (2010) 1.26
Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia (2006) 1.24
Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol (2011) 1.24
Blood-brain barrier alterations in ageing and dementia. J Neurol Sci (2009) 1.24
Significance of MDR1 and multiple drug resistance in refractory human epileptic brain. BMC Med (2004) 1.23
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol (2005) 1.20
Epilepsy biomarkers. Epilepsia (2013) 1.19
Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci (2005) 1.19
Inflammation and prevention of epileptogenesis. Neurosci Lett (2011) 1.18
Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia (2006) 1.17
Insulin causes hyperthermia by direct inhibition of warm-sensitive neurons. Diabetes (2009) 1.16
Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia (2005) 1.16
Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain (2011) 1.16
High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products. Exp Neurol (2011) 1.13
Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. Sleep (2004) 1.13
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Eur J Neurosci (2005) 1.10
Histamine influences body temperature by acting at H1 and H3 receptors on distinct populations of preoptic neurons. J Neurosci (2010) 1.09
Astrocyte immune responses in epilepsy. Glia (2012) 1.09
Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol Dis (2009) 1.07
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers. J Alzheimers Dis (2013) 1.07
Gene therapy in epilepsy: the focus on NPY. Peptides (2006) 1.04
The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology (2008) 1.04
Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis (2011) 1.04
Antiepileptic effects of botulinum neurotoxin E. J Neurosci (2005) 1.03
Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release. J Neurochem (2008) 1.01
Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid Redox Signal (2014) 1.00
Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res (2002) 1.00
A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci U S A (2005) 0.99
Activation of σ-receptors induces binge-like drinking in Sardinian alcohol-preferring rats. Neuropsychopharmacology (2011) 0.98
G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice. J Clin Invest (2012) 0.97
Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol (2008) 0.97
Beta-amyloid protein structure determines the nature of cytokine release from rat microglia. J Mol Neurosci (2005) 0.97
Interleukin-18 and stress. Brain Res Rev (2007) 0.96
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Dement Geriatr Cogn Disord (2009) 0.96
The activation of P2X7 receptor induces cathepsin D-dependent production of a 20-kDa form of IL-1β under acidic extracellular pH in LPS-primed microglial cells. J Neurochem (2011) 0.95
Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides (2008) 0.95
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc Natl Acad Sci U S A (2010) 0.95
Metabolic characterization of a mouse deficient in all known leptin receptor isoforms. Cell Mol Neurobiol (2009) 0.95
Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance. Swiss Med Wkly (2008) 0.95
Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis. Epilepsia (2012) 0.95
Neuronal Sirt1 deficiency increases insulin sensitivity in both brain and peripheral tissues. J Biol Chem (2013) 0.94
Night eating and obesity in the EP3R-deficient mouse. Proc Natl Acad Sci U S A (2007) 0.94
Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics (2009) 0.93
Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease. Neurochem Int (2005) 0.92
Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development. Neurobiol Dis (2006) 0.92
Sex- and age-specific differences in core body temperature of C57Bl/6 mice. Age (Dordr) (2010) 0.92
Impaired long term memory consolidation in transgenic mice overexpressing the human soluble form of IL-1ra in the brain. J Neuroimmunol (2009) 0.91
Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse. Acta Neuropathol (2004) 0.91
alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides (2006) 0.91
Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. Eur J Neurosci (2008) 0.91
A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. Epilepsia (2005) 0.91
Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia (2012) 0.91
Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis (2013) 0.90
Metabolic depression and increased reactive oxygen species production by isolated mitochondria at moderately lower temperatures. J Biol Chem (2010) 0.89
Cutting edge: IL-13Rα1 expression in dopaminergic neurons contributes to their oxidative stress-mediated loss following chronic peripheral treatment with lipopolysaccharide. J Immunol (2012) 0.89
Tissue-resident memory CD8+ T cells can be deleted by soluble, but not cross-presented antigen. J Immunol (2005) 0.88
Molecules affecting hypothalamic control of core body temperature in response to calorie intake. Front Genet (2012) 0.88
NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus (2008) 0.88
Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3. J Virol (2004) 0.87
Interplay between human microglia and neural stem/progenitor cells in an allogeneic co-culture model. J Cell Mol Med (2013) 0.87
Hypothalamic and dietary control of temperature-mediated longevity. Ageing Res Rev (2009) 0.87
IL-1β is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence. Neurobiol Dis (2011) 0.86
Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study. J Lipid Res (2009) 0.86
Kv4.2 mediates histamine modulation of preoptic neuron activity and body temperature. PLoS One (2011) 0.86
Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines. Brain Behav Immun (2005) 0.86
In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia (2012) 0.86
The influence of kainic acid on core temperature and cytokine levels in the brain. Cytokine (2006) 0.86
Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone. Neurotox Res (2005) 0.86